10 Best Immunotherapy Stocks to Buy Now
The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.
Amgen Inc (AMGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 1,054,800 | $339,867,108 | -14% | 0.06% | |
| 2. | 1,014,700 | $326,946,487 | -30% | 0.06% | |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 784,900 | $252,902,629 | +10% | 0.59% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 705,111 | $227,193,816 | +8% | 0.27% |
| 5. | Adage Capital Management Phill Gross And Robert Atchinson | 601,662 | $193,861,513 | +5% | 0.34% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.50 | 10 | Director | 3,582 | 2015-08-19 | Filing | |
| $166.64 | 3,000 | Director | 3,572 | 2015-08-19 | Filing | |
| $152.29 | 1,500 | Director | 2,000 | 2015-02-05 | Filing | |
| $152.29 | 1,500 | Director | 2,000 | 2015-02-05 | Filing | |
| $111.77 | 894 | Officer, Director | 185,013 | 2014-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $313.09 | 2,117 | Officer | 9,883 | 2024-05-03 | Filing | |
| $273.03 | 2,096 | Officer | 10,874 | 2023-12-04 | Filing | |
| $272.81 | 10,000 | Officer | 28,078 | 2023-11-08 | Filing | |
| $262.43 | 9,558 | Officer | 44,308 | 2023-08-10 | Filing | |
| $292.90 | 387 | Officer | 6,630 | 2022-11-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 49,036,311 | $14,123,438,295 | 0.3% | |
| 2. | 47,812,390 | $13,770,924,367 | 0.35% | |
| 3. | 29,463,970 | $8,486,212,639 | 0.41% | |
| 4. | 14,591,468 | $4,202,634,613 | 3.32% | |
| 5. | 14,434,062 | $4,157,299,397 | 0.36% |
News See All
10 Best Pharma Stocks To Buy Right Now
Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of new treatments, and design...
Amgen Inc. (NASDAQ:AMGN) Q3 2024 Earnings Call Transcript
Operator: My name is Julianne, and I will be your conference facilitator today for Amgen's Third Quarter 2024 Financial Results Conference Call.
10 Buzzing AI Health Stocks
The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are expected to see GDP boosts of 26% and 14.5%, respectively, by 2030, amounting ...
Amgen (AMGN) Rose Owing To The Announcement Of Promising Data For Its Novel Medication
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Healthcare Stocks To Buy According to Hedge Funds
Investing in healthcare equities is typically seen as protective during difficult economic times.
10 Undervalued Wide Moat Stocks to Buy According to Analysts
The US economy was able to pass its first soft-landing test by exhibiting resilience through the risky disinflation process. Market experts believe that inflation has now markedly cooled, enabling the...
Amgen Inc. (AMGN): A Bull Case Theory
We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article we will summarize the bulls’ thesis on AMGN. AMGN Technologies, Inc.
10 Stocks That Will Change the World
If we were to try and summarize one of the biggest ways how to make money on the stock market, it'd include buying stocks of firms that have changed the world.
Amgen Inc. (NASDAQ:AMGN) Q2 2024 Earnings Call Transcript
Operator: My name is Julianne, and I will be your conference facilitator today for Amgen's Second Quarter 2024 Financial Results Conference Call.
Billionaire Hedge Funds
